HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sperm concentration, testicular volume and age predict risk of carcinoma in situ in contralateral testis of men with testicular germ cell cancer.

AbstractPURPOSE:
We investigated whether semen quality or some easily attainable clinical parameters might be used to estimate the risk of contralateral carcinoma in situ in patients with unilateral testicular germ cell tumors.
MATERIALS AND METHODS:
A total of 264 Danish patients with testicular germ cell tumor with or without contralateral testicular carcinoma in situ were retrospectively investigated. Clinical data included andrological history, physical examination, testis ultrasonography, semen quality and testis histology. Study groups were compared by univariate linear regression analysis and the chi-square test. Associations between contralateral carcinoma in situ and risk factors were modeled in 2 stages: Bayes rule was used to assess the probability of carcinoma in situ; the terms in Bayes rule were estimated using regression models.
RESULTS:
Significant characteristics of patients with contralateral carcinoma in situ were lower sperm concentration, smaller contralateral testis volume, irregular ultrasonic echo pattern of the contralateral testis and younger age. Cutoff values of sperm concentration and testicular volume were defined. However, according to these only a minority of the noncarcinoma in situ cases could potentially have been spared a diagnostic testicular biopsy. Combining information on age and sperm concentration, secondly age and testis volume resulted in models of the estimated contralateral carcinoma in situ risk, from which patients at particular high risk of carcinoma in situ could be identified.
CONCLUSIONS:
The combined information on sperm concentration, age and contralateral testis volume predict the risk of contralateral carcinoma in situ in patients with unilateral testicular germ cell tumor. The proposed models may facilitate selection of patients with testicular germ cell tumor for contralateral testicular biopsy at the time of orchiectomy if this is not routinely done.
AuthorsCamilla Nymann Rud, Gedske Daugaard, Ewa Rajpert-De Meyts, Niels E Skakkebæk, Jørgen Holm Petersen, Niels Jørgensen
JournalThe Journal of urology (J Urol) Vol. 190 Issue 6 Pg. 2074-80 (Dec 2013) ISSN: 1527-3792 [Electronic] United States
PMID23770148 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.
Topics
  • Adolescent
  • Adult
  • Age Factors
  • Carcinoma in Situ (pathology)
  • Humans
  • Male
  • Middle Aged
  • Neoplasms, Germ Cell and Embryonal (pathology)
  • Neoplasms, Multiple Primary (pathology)
  • Organ Size
  • Prognosis
  • Retrospective Studies
  • Risk Assessment
  • Sperm Count
  • Testicular Neoplasms (pathology)
  • Testis (pathology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: